Euromonitor International’s Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Forestry market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Product coverage: Forestry and Logging, Transport of Logs.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Forestry market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Our reports have been used by over 10K customers, including:
Asia-Pacific Orthopedic Power Tools and Consumables Market Outlook to 2025 - Consumables and Power Tools
Summary
“Asia - Pacific Orthopedic Power Tools and Consumables Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Asia - Pacific Orthopedic Power Tools...
2021 Japan Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report is a study of the major business...
275 pages •
By Global Industry Analysts
• Mar 2021
Project Details:
- StrategyR - A Trademark of Global Industry Analysts, Inc.
- Project Edition: 5
- Influencer Pool: 1067
- MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....
“LONCASTUXIMAB TESIRINE- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed picture of the LONCASTUXIMAB TESIRINE in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United...
Overview
“Leustatin - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Leustatin in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...
“CSL312 - Emerging Insight and Market Forecast- 2030” the report provides comprehensive insights about an investigational product for Hereditary Angioedema (HAE) in 7 Major Markets. A detailed picture of the CSL312 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study...
“VIB7734 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cutaneous Lupus Erythematosus in 7 Major Markets. A detailed picture of the VIB7734 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for...
“Qbrexza - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Qbrexza in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2017–2030...
Overview
“Phesgo - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Phesgo in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for...
Overview
“ Kalydeco - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Kalydeco in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...
Cystic Fibrosis
Clinical Trial
Hospital
Europe
Japan
World
Spain
France
Germany
Italy
United Kingdom
United States
Health Expenditure
Use Of Prescription Drugs
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.